Ian Marks is a senior executive with over 25 years in the pharmaceutical and consumer healthcare industry.
He has have extensive experience delivering breakthrough innovations, leading disruptive initiatives, cultivating unorthodox partnerships, and building strategic capabilities that improve patients' lives and drive business value.
He is a recognized thought-leader in transforming healthcare through disruptive innovation with a following of 24k professionals on LinkedIn.
My experience encompasses research and development, project management, clinical research and operations across Pharma and Consumer Healthcare. I have successfully leveraged ‘breakthrough’ results and superior performance to effectively merge patient insights, digital innovation, product development and compelling scientific discovery that identifies new products and experiences.
He has applied industry-leading capabilities to create an innovation pipeline that integrated three core principles, including: (1) deep and robust insight into patient needs; (2) a strong collaborative and holistic approach to drug development; and (3) an entrepreneurial spirit characterized by a 'fast-fail/test and learn' approach that enabled superior results.
He has have extensive experience delivering breakthrough innovations, leading disruptive initiatives, cultivating unorthodox partnerships, and building strategic capabilities that improve patients' lives and drive business value.
He is a recognized thought-leader in transforming healthcare through disruptive innovation with a following of 24k professionals on LinkedIn.
My experience encompasses research and development, project management, clinical research and operations across Pharma and Consumer Healthcare. I have successfully leveraged ‘breakthrough’ results and superior performance to effectively merge patient insights, digital innovation, product development and compelling scientific discovery that identifies new products and experiences.
He has applied industry-leading capabilities to create an innovation pipeline that integrated three core principles, including: (1) deep and robust insight into patient needs; (2) a strong collaborative and holistic approach to drug development; and (3) an entrepreneurial spirit characterized by a 'fast-fail/test and learn' approach that enabled superior results.
Speaking In
2:15 PM - 3:15 PM
Monday, June 5
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
